Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2017 | 1 |
2020 | 1 |
2024 | 0 |
Search Results
2 results
Results by year
Filters applied: . Clear all
Page 1
Metabolism, pharmacokinetics, and bioavailability of ZB716, a Steroidal Selective Estrogen Receptor Downregulator (SERD).
Oncotarget. 2017 Oct 10;8(61):103874-103889. doi: 10.18632/oncotarget.21808. eCollection 2017 Nov 28.
Oncotarget. 2017.
PMID: 29262607
Free PMC article.
GLL398, an oral selective estrogen receptor degrader (SERD), blocks tumor growth in xenograft breast cancer models.
Guo S, Zhang C, Mottamal M, Hossain A, Liu J, Wang G.
Guo S, et al.
Breast Cancer Res Treat. 2020 Apr;180(2):359-368. doi: 10.1007/s10549-020-05558-w. Epub 2020 Feb 6.
Breast Cancer Res Treat. 2020.
PMID: 32030569
Free PMC article.
Item in Clipboard
Cite
Cite